Full Press Release Details
ALX Oncology to Present at the 2026 Jefferies Global Healthcare Conference in New York.
ALXO
ALX Oncology to Present at the 2026 Jefferies Global Healthcare Conference in New York
Key Takeaway: ALX Oncology to Present at the 2026 Jefferies Global Healthcare Conference in New York
Price reaction · baseline $1.9 (2026-05-29 close) · clean, no other ALXO news in the window
day 0 close
-5.3%
day 1
-6.3%
day 3 · peak
-17.9%
Conference Participation Details
Jefferies Global Healthcare Conference
Date: November 18, 2025
Time: 11:30 a.m. GMT / 6:30 a.m. ET
Location: London
Format: Fireside Chat
How to Access
Investors and the general public can listen to both sessions live at:
https://investor.viatris.comArchived versions will be available following the live events for a limited time.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+102%
120-day peak, hindsight
Typical move
7.9%
average across 6 past catalysts
Cash runway
~25 mo
Minimal dilution risk
Lead asset
ALX2004
Phase 1 · NSCLC (Advanced Non-small Cell Lung Cancer)